Short is not
the same as small.

Measured with
questionnaires.

Studies assess shifts in self-experience, perceived boundaries, emotion and meaning.

A 2021 dose-finding study of an inhaled formulation measured mystical-type experience and ego dissolution in 22 healthy volunteers. Higher studied dose conditions generally produced stronger ratings — without demonstrating any treatment benefit in that healthy sample.

A 2025 study combining interviews, questionnaires and EEG found variable changes in bodily and narrative self-experience. Only some of the more extreme accounts described awareness without identifiable content. These are retrospective descriptions of what people remember, not proof of a claim about the nature of mind.

Experiences differ between people. Neither bliss nor any particular spiritual interpretation is guaranteed, and a powerful experience is not self-validating.

Fourteen minutes,
in one study.

The often-quoted number comes from a specific formulation in a specific setting.

In the 2021 inhaled study, investigators estimated an average acute experience of about 14 minutes. Participants estimated about 18. Those averages describe that study — that product, that route, that observed setting — and not a personal countdown.

An intranasal formulation has its own absorption and elimination profile. A timeline from one route does not transfer to another, and numerical amounts across products are not interchangeable doses.

This page gives no doses. A published dose is inseparable from the tested product, delivery device, participant selection and medical observation around it, and the research does not establish an amount that is safe for any particular person.

The peak is not
the episode.

Preparation, observation and recovery extend well beyond an acute peak.

Fifteen minutes describes the part of the experience that can be timed. It says nothing about the hours afterwards, the days of reorientation some people describe, or the weeks in which an experience either becomes something or does not.

Aspects of an experience can also return later, after the acute effects have passed. An exploratory analysis of 513 survey responses found these recurrences reported at different rates in different samples — most neutral or positive, some not.

So the honest answer to how long it lasts is that the acute part is short, the episode is not, and the difference between those two is where most of the difficulty and most of the value sit.

Stronger is not
better.

Greater subjective intensity should not be read as greater benefit.

Bodily discomfort and psychological distress are not evidence of progress and should not be automatically reinterpreted as such. An experience that was overwhelming is not thereby more valuable than one that was not, and the research gives no basis for treating intensity as a measure of anything except intensity.